GenScript Biotech Corporation (HKG: 1548), a leading Chinese biotechnology company, has announced the establishment of a new operations site and logistics center in Sydney, Australia. This strategic move highlights GenScript’s commitment to supporting the burgeoning biotechnology sector in Australia.
Sydney Facility’s Role in Streamlining Operations
The new Sydney facility is designed to enhance GenScript’s ability to deliver research reagents and products more quickly and efficiently to customers throughout the region. By establishing a local presence, GenScript aims to simplify the procurement process for researchers and biotech companies in Australia by handling permit applications, customs clearance, and tax payments, allowing them to concentrate on their research and innovation.
Next-Day Shipping for High-Demand Products
A key feature of the Sydney facility is the introduction of next-day shipping for high-demand products, including off-the-shelf mRNA, growth factors, Cas proteins, and more. This service will significantly expedite researchers’ and biotech companies’ access to essential materials, thereby supporting their scientific discoveries and development efforts.-Fineline Info & Tech
Leave a Reply